Compare TROO & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TROO | PROF |
|---|---|---|
| Founded | 2005 | N/A |
| Country | Hong Kong | Canada |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 480.1M | 230.4M |
| IPO Year | 2008 | 2017 |
| Metric | TROO | PROF |
|---|---|---|
| Price | $2.83 | $7.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 484.3K | 155.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $10,680,000.00 |
| Revenue This Year | N/A | $61.09 |
| Revenue Next Year | N/A | $120.94 |
| P/E Ratio | ★ N/A | $6.57 |
| Revenue Growth | N/A | ★ 48.35 |
| 52 Week Low | $0.50 | $3.90 |
| 52 Week High | $5.28 | $8.95 |
| Indicator | TROO | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 40.13 | 51.74 |
| Support Level | $0.89 | $7.00 |
| Resistance Level | $4.45 | $7.95 |
| Average True Range (ATR) | 0.44 | 0.42 |
| MACD | -0.12 | 0.10 |
| Stochastic Oscillator | 4.83 | 65.32 |
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.